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Research Article 
INTRODUCTION  
In the entire world, an estimated 300 million people are 
exposed to arsenic toxicity. Arsenic poisoning in the 
groundwater has caused severe health hazards in the 
population (Chakraborti et al., 2018).  In Bihar, 18 out of 
38 districts are severely affected, exposing nearly 10 
million people to groundwater arsenic contamination. 
Most of the arsenic affected districts in the state are 
from the Gangetic flood plain region (Chakraborti et al., 
2003).  The people living in these arsenic affected areas 
have been reported with several skin manifestations 
(keratosis, melanosis, raindrop pigmentation, etc.),  
gastrointestinal disorders, hormonal imbalance, general 
body weakness, reproductive disorders and cancer 
(Kumar et al., 2015a).  
Arsenic is present naturally in both organic and  
inorganic forms in the environment. Trivalent arsenic 
(arsenite) is more toxic to humans as compared to  
pentavalent arsenic (arsenate). The trivalent form of 
arsenic travels into the cells through aquaglyceroporins 
(Liu et al., 2001). Due to high lipid solubility, trivalent 
compounds are absorbed more rapidly than their pen-
tavalent form (Ellenhorn et al., 1997). The ingested 
soluble form of arsenic is very easily absorbed from the 
gastrointestinal tract into the bloodstream and gets dis-
tributed to various organs such as the liver, kidney, 
lungs and skin (Hunter et al., 1942). Among the various 
organs, liver and kidney are the major target organ for 
arsenic induced toxicity, because they play vital role in 
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metabolism and excretion, respectively (Ratnaike, 
2003). Several studies reported that during arsenic me-
tabolism, cells generate reactive oxygen species (ROS) 
and free radicals, which damage the cellular macromol-
ecules and disrupt the cellular signaling pathways that 
play role in arsenic-mediated disease manifestation 
(Barai et al., 2017; Sohini, 2007). In addition, chronic 
inorganic arsenic exposure also enhances the suscepti-
bility of the cells to chromosomal aberration, oxidative 
stress, cell proliferation and inhibiting the DNA repair 
process, ultimately leading to cancer (Bhattacharya, 
2019).  
Presently, there are very meagre antidotes available for 
arsenic toxicity. Hence there is an immense need for 
the development of safe and effective drugs. The devel-
opment of a nutritional supplement or drug discovery 
approach to this problem is a novel initiative (Singh et 
al., 2007).  The secondary metabolites and phytoconstit-
uents from the plant sources are being explored for the 
novel drug development and diet supplement. One 
such potential plant source is fenugreek (Trigonella 
foenum-graecum L.) which belongs to Fabaceae family. 
The phytochemical screening of fenugreek seeds 
showed the presence of alkaloids, flavonoids, saponins, 
free amino acids, proteins, glycosides and mucilaginous 
fibers (Wani and Kumar, 2018). Several pharmacologi-
cal properties of fenugreek seeds such as antidiabetic, 
antioxidative, hypocholesterolemic, antiulcerogenic, 
antineoplastic, antipyretic, anti-inflammatory, anti-toxic, 
immunomodulatory and antitumor have been reported 
(Wani and Kumar, 2018). 
Therefore, this study was designed and planned to 
evaluate the therapeutic potential of fenugreek ethanol-
ic seeds extract against arsenic induced liver and kid-
ney toxicity in Charles Foster rats.  
MATERIALS AND METHODS 
Chemicals  
Arsenic was used as sodium (meta) arsenite (90%) 
manufactured by Sigma-Aldrich, USA (CAS Number: 
7784-46-5; S7400-100G), Lot# SLBH5736V, PCode 
1001683292 was purchased from the licensed and ap-
proved scientific store present in Patna, Bihar, India. 
Preparation of ethanolic extract of fenugreek 
(Trigonella foenum-graecum) seeds 
Fenugreek seeds were purchased from the local market 
of Patna, Bihar and identified by Dr. Sushil Kr Singh 
(Botanist), Associate Professor, Department of Biotech-
nology, A. N. College Patna, Bihar, India. The Interna-
tional Plant Names Index (IPNI) Life Sciences Identifier 
(LSID) number of fenugreek (T. foenum-graecum L.), is 
58514-3 (IPNI, 1753).  The plant seeds were properly 
washed through running tap water and dried in the incu-
bator at 37°C temperature. After that, the dried seeds 
were ground into a fine powder, which was further 
soaked in absolute ethanol for 48 hours. The ethanolic 
extract was separated by using rota vapour apparatus 
(Buchi, R-3, Switzerland). The ethanolic extract dose 
was calculated after LD50 estimation, and the final dose 
was titrated to 250 mg/kg body weight. 
Animals 
Twenty-four healthy male Charles Foster rats (8 weeks 
old) weighing 160-180 g were used for this study. The 
rats were provided by the animal house of Mahavir 
Cancer Sansthan and Research Centre, Patna, India 
(CPCSEA Reg-No. 1129/bc/07/CPCSEA). The animal 
experimentation work was approved by the Institutional 
Animal Ethics Committee (IAEC) of Mahavir Cancer 
Santhan and Research Centre, Patna, Bihar with the 
IAEC No. 2017/1F-10/08/17. All rats were acclimatized 
to laboratory housing conditions under 12-hour light 
and dark cycles (room temperature maintained at 24 ± 
2°C) for 15 days prior to the beginning of the treatment 
under standard laboratory conditions. These experi-
mental rats were housed in conventional polypropylene 
cages and stainless-steel grill top having 2 rats in each 
cage. Food (self-prepared by the laboratory) and water 
to rats were provided ad libitum.  
Experimental design 
Rats were randomly separated into the following 
groups:  
Group I: Control (n=6) - Rats were used as control.  
Group II: Arsenic treated (n=6) - Rats were orally treat-
ed with sodium arsenite (8 mg/kg body weight/day) for 
90 days.  
Group III: Arsenic pretreated control (n=6) - Rats were 
orally treated with sodium arsenite (8 mg/kg body 
weight/day) for 90 days and left without any treatment 
up to next 90 days for auto recovery observation.  
Group IV: Fenugreek administration (n=6) - Rats were 
orally administered fenugreek (Trigonella foenum-
graecum) ethanolic seeds extract (250 mg/kg body 
weight/day) for 90 days upon the arsenic pretreated 
rats (8 mg/kg body weight/day for 90 days). 
After the completion of the entire treatment, rats were 
anesthetized by diethyl ether and sacrificed. Blood 
samples were collected in EDTA- coated and plane 
vacutainer through the orbital puncture from all the 
groups. Serum was extracted for the various biochemi-
cal estimations. The liver and kidney tissues were also 
dissected out for the histopathological study and arse-
nic concentration determination. 
Haematological parameters assay 
The whole blood collected in EDTA-coated vacutainer 
was used for haematological estimation. The red blood 
cells (RBC), haemoglobin (HGB), Haematocrit (HCT), 
Mean corpuscular haemoglobin (MCH), Mean corpus-
1084 
 
Kumar, V. et al. / J. Appl. & Nat. Sci. 13(3), 1083 - 1093 (2021) 
cular volume (MCV), platelets (PLT) and white blood 
cells (WBC) were immediately analyzed by using fully 
automated haematological analyzer (BC-2800, Min-
dray, China). 
Biochemical parameters assay  
The various Liver and Kidney biochemical parameters 
such as serum glutamate pyruvate transaminase 
(SGPT), serum glutamate oxaloacetate transaminase 
(SGOT), alkaline phosphatase (ALP), total bilirubin, 
urea, creatinine, uric acid, and albumin were assayed 
using standard Kit manufactured by Coral Clinical Sys-
tems, India, through (UV - Vis) spectrophotometer (UV-
10, Thermo Scientific, USA).  
Lipid peroxidation (LPO) assay 
Thiobarbituric acid reactive substances (TBARS), as a 
marker of LPO, were evaluated through the double 
heating method (Draper HH, Hadley, 1990). The meth-
od is based on the principle of spectrophotometric 
measurement of color reproduced in reaction with thio-
barbituric acid (TBA) and malondialdehyde (MDA). For 
this study, 2.5 mL of 100 g/L solution of trichloroacetic 
acid (TCA) was mixed with 0.5 mL serum in a centri-
fuge tube and heated in the water bath at 90°C for 15 
minutes. After cooling at room temperature, the mixture 
was further allowed to centrifuge at 3000 rpm for 10 
minutes, and 2 mL of the supernatant was mixed with 1 
mL of 6.7 g/L TBA solution in test tube which was fur-
ther heated in water bath at 90°C for 15 minutes and 
left for cooling at the room temperature. Thereafter, 
absorbance was measured by UV - Visible spectropho-
tometer (UV-10, Thermo Scientific USA) at 532 nm.  
Arsenic concentration determination in blood, liver 
and kidney tissues 
The whole blood, liver and kidney tissue samples were 
utilized for arsenic estimation using Atomic Absorption 
Spectrophotometer. The blood and tissue samples 
were digested using concentrated HNO3 on a hot plate 
under the fume hood and estimated as per the protocol 
of NIOSH (1994) and the concentration was read 
through Graphite Furnace Atomic Absorption Spectro-
photometer (Pinnacle 900T, Perkin Elmer, Singapore) 
at Mahavir Cancer Sansthan and Research Centre, 
Patna, Bihar. 
Histopathological study 
For the histopathological study, liver and kidney tissues 
were dissected from all the groups of rats and washed 
in normal saline, grossed into small pieces and finally 
fixed in 10% formalin for 24 hours. The tissue samples 
were moved for the dehydration process, through se-
ries of ethanol concentration and finally embedded into 
paraffin. Thin sections of 5µm thickness were cut by 
digital rotary microtome (Microm HM 340E, Thermo 
Scientific USA) and stained with hematoxylin and eosin 
(H&E) for the analysis of histopathological changes 
under light microscope. 
Statistical analysis 
Results are presented as mean ± standard deviation 
(SD) for six rats in each group. Total variation was rep-
resented in a set of data and was analyzed through 
one-way analysis of variance (ANOVA) followed by 
Tukey test with multiple comparisons. The value p < 
0.05 was considered as statistically significant. Calcu-
lations were performed with the GraphPad Prism pro-
gram (GraphPad 5.0 Software, Inc., San Diego, USA).  
RESULTS 
Effects on the haematological parameters in rats 
The haematological parameters showed that there 
were significant (p < 0.0001) changes in the RBC, 
HGB, HCT, WBC and platelets (p < 0.05) counts, while 
there were non-significant changes in the MCV and 
MCH levels in the arsenic treated group in comparison 
to the control group. Moreover, in arsenic pretreated 
control group, which was left for auto recovery for 90 
days after arsenic administration, had a significant (p < 
0.05) decrease in the WBC counts and non-significant 
changes observed in RBC, HGB, HCT, MCV, MCH and 
platelets counts in comparison to the arsenic treated 
group. However, significant (p < 0.0001) restoration 
were observed in the RBC, HGB, HCT and WBC 
count, while non-significant changes were observed in 
the MCV, MCH and platelets count in the fenugreek 
seeds extract treated group in comparison to the arse-
nic pretreated control group (Table 1). 
Effect on the arsenic concentration in blood, liver 
and kidney tissues of rats 
The results showed that the arsenic treated group had 
significant (p < 0.0001) arsenic accumulation in the blood, 
liver and kidney tissues compared to the control group. 
Moreover, in the arsenic pretreated control group, which 
was left for auto recovery for 90 days after arsenic admin-
istration, had significant (p < 0.0001) reduction in the arse-
nic concentration (accumulation) in blood, liver and kidney 
tissues in comparison to the arsenic treated group. Fur-
thermore, fenugreek seeds extract administration upon 
arsenic pretreated rats resulted in significant (p < 0.0001) 
reduction in the arsenic concentration in blood, liver and 
kidney tissues in comparison to the arsenic pretreated 
control group (Table 2). 
Effects on the serum hepatic biomarker parameters 
in rats 
The results showed that, arsenic treated rats had sig-
nificant (p < 0.0001) increase in the serum SGPT, 
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SGOT, ALP and total bilirubin levels in comparison to 
the control group. However, arsenic pretreated control 
group rats, which were left for auto recovery for 90 
days after arsenic administration, had significant (p < 
0.0001) decrease in the SGPT, SGOT, total bilirubin 
and ALP (p < 0.05) levels in comparison to the arsenic 
treated group. But, after the administration with fenu-
greek seeds extract at the dose of 250 mg/kg body 
weight per day for 90 days upon arsenic pretreated 
rats, showed the protective effect against arsenic in-
duced hepatotoxicity as there was significant (p < 
0.0001) decrease in the levels of SGPT, SGOT, ALP 
and total bilirubin in comparison to the arsenic pretreat-
ed control group (Figs. 1-4). 
Effects on the serum renal biomarker parameters in 
rats 
In the arsenic treated group rats, there was a significant 
(p < 0.0001) increase in the serum levels of urea, uric 
acid and creatinine, while there was a significant (p < 
0.0001) decrease in the serum albumin levels in com-
parison to the control group. However, arsenic pretreat-
ed control group, which was left for auto recovery for 90 
days after arsenic administration, had a significant (p < 
0.05) decrease in the serum levels of urea, uric acid 
and creatinine (p < 0.0001), while the non-significant 
changes observed in the albumin levels in comparison 
to the arsenic treated group. But, after the administra-
tion with fenugreek seeds extract at the dose of 250 
mg/kg body weight per day for 90 days upon arsenic 
pretreated rats, there was significant (p < 0.0001) de-
crease in the urea, uric acid and creatinine levels, while 
significant increase (p < 0.0001) in the albumin levels 
were observed as compared to the arsenic pretreated 
control group, denoting the protective effect of fenu-
greek seeds against arsenic induced renal toxicity 
(Figs. 5-8). 
Effect on the serum lipid peroxidation (MDA) in rats 
In the arsenic treated rats, there was significant (p < 
0.0001) increase in the serum MDA levels in compari-
son to the control group. However, in arsenic pretreated 
control group, which was left for auto recovery for 90 
days after arsenic administration had significant (p < 
0.001) decrease in the serum MDA levels. But, after 
administration with fenugreek seeds extract at the dose 
of 250 mg/kg body weight per day for 90 days upon 
arsenic pretreated rats, there was significant (p < 
0.0001) decrease in the serum MDA levels in compari-
son to the arsenic pretreated control group, denoting 
the antioxidant activity of fenugreek seeds (Fig. 9). 
Histopathological study of liver 
In the histopathological study, the control group rat liver 
section showed normal architecture of central vein with 
hepatocytes well arranged in the sinusoids (Fig. 10A). 
The arsenic treated rat liver section showed significant 
degeneration of hepatocytes, dilatation in sinusoids and 
haemorrhage in portal vein (Fig. 10B). The arsenic pre-
treated control rat liver section also showed high de-
gree of dilatation and vacuolizations in sinusoids along 










RBC (×106/mm3) 8.46 ± 1.12 3.78 ± 1.17*** 4.91 ± 1.63ns 8.68 ± 0.78### 
HGB (g/dL) 14.32 ± 0.84 7.80 ± 1.42*** 9.33 ± 1.29ns 15.57 ± 1.38### 
HCT (%) 39.77 ± 2.42 20.83 ± 4.46*** 26.23 ± 4.21ns 43.03 ± 3.78### 
MCV (fL) 47.55 ± 6.44 56.73 ± 8.70ns† 58.78 ± 12.41ns 49.55 ± 1.50ns†† 
MCH (pg) 17.10 ± 2.22 21.65 ± 4.89ns† 20.50 ± 5.81ns 17.88 ± 0.44 ns†† 
WBC (×103/mm3) 8.46 ± 1.77 14.05 ± 2.08*** 11.23 ± 1.28^ 7.01 ± 1.01### 
Platelets (×103/mm3) 728.8 ± 106.1 452.3 ± 160.2* 615.5 ± 150.0ns 778.0 ± 167.1ns†† 
Table 1. Haematological parameters in control and treatment groups of rats 
Haematological parameters in different treated group (control and treatment groups). Values are expressed as mean ± SD, n=6; ***(p < 
0.0001), *(P < 0.05), ns†(non-significant) compared with control group; ^(p < 0.05), ns(non-significant) compared with arsenic treated 










Blood (µg/L) 0.23 ± 0.07 133.4 ± 5.05*** 81.28 ± 7.03^^^ 11.11 ± 3.42### 
Liver (µg/kg) 0.91 ± 0.16 174.0 ± 6.24*** 110.3 ± 7.55^^^ 15.30 ± 2.88### 
Kidney (µg/kg) 0.42 ± 0.13 96.57 ± 5.04*** 76.38 ± 4.83^^^ 32.14 ± 4.20### 
Arsenic concentration levels in different treated group of rats’ tissues (control and treatment groups); Values are expressed as mean ± 
SD, n=6; ***(p < 0.0001) compared with control group; ^^^(p < 0.0001) compared with arsenic treated group; ###(p < 0.0001) compared 
with arsenic pretreated control group 
Table 2. Levels of arsenic concentration in control and treatment groups of rats tissues 
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Fig. 2. SGOT levels in different treated groups (control 
and treatment group). Values are expressed as mean ± 
SD, n=6; ***(p < 0.0001) compared with control group; ^^^
(p < 0.0001) compared with arsenic treated group; ###(p < 
0.0001) compared with arsenic pretreated control group 
Fig. 1. SGPT levels in different treated groups (control and 
treatment group). Values are expressed as mean ± SD, 
n=6; ***(p < 0.0001) compared with control group; ^^^(p < 
0.0001) compared with arsenic treated group; ### (p < 
0.0001) compared with arsenic pretreated control group 
Fig. 6. Uric acid levels in different treated groups (control 
and treatment group). Values are expressed as mean ± 
SD, n=6; ***(p < 0.0001) compared with control group; ^(p 
< 0.05) compared with arsenic treated group; ### (p < 
0.0001) compared with arsenic pretreated control group 
Fig. 5. Urea levels in different treated groups (control and 
treatment group). Values are expressed as mean ± SD, 
n=6; ***(p < 0.0001) compared with control group; ^(p < 
0.05) compared with arsenic treated group; ### (p < 0.0001) 
compared with arsenic pretreated control group 
Fig. 4.  Total bilirubin levels in different treated groups 
(control and treatment group). Values are expressed as 
mean ± SD, n=6; ***(p < 0.0001) compared with control 
group; ^^^(p < 0.0001) compared with arsenic treated 
group; ###(p < 0.0001) compared with arsenic pretreated 
control group 
Fig. 3. ALP levels in different treated groups (control and 
treatment group). Values are expressed as mean ± SD, 
n=6; ***(p < 0.0001) compared with control group; ^(p < 
0.05) compared with arsenic treated group; ###(p < 0.0001) 
compared with arsenic pretreated control group 
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which denotes no auto repair mechanism in the cells 
(Fig. 10C). The fenugreek seeds extract administration 
upon arsenic pretreated rat liver section showed signifi-
cant restoration in the hepatocytes along with the mild 
degeneration in portal vein, which was almost recov-
ered from the deleterious effect of arsenic toxicity (Fig. 
10D).  
Histopathological study of kidney 
In this histopathological study, control rat kidney sec-
tion showed normal architecture of glomerulus in Bow-
man’s capsule (Fig. 11A). The arsenic treated rat kid-
ney section showed degeneration in glomerulus; vacu-
olization in Bowman’s capsule along with distal and 
proximal convoluted tubules (Fig. 11B). The arsenic 
pretreated control rats also showed persistence of  
degeneration in nephrocytes, glomerulus and Bow-
man’s capsule as well as vacuolization and haemor-
rhage in renal convoluted tubules which indicates no 
auto amelioration from arsenic intoxication (Fig. 11C). 
The fenugreek seeds extract administration upon arse-
nic pretreated rat kidney section showed significant 
restoration in the glomerulus and Bowman’s capsule 
along with the persistence of mild vacuolization in distal 
and proximal convoluted tubules compared to arsenic 
treated rat’s kidney section (Fig. 11D).  
DISCUSSION 
Prolonged exposure to arsenic is known to cause sev-
eral toxic effects involving multiple organ systems with 
complex mechanisms. Arsenic is a well-known toxicant 
that affects hematological parameters like platelets, 
HGB, RBC, WBC, HCT, MCV and MCH. The present 
study showed significant changes in RBC, HGB, HCT, 
WBC and platelets counts after arsenic treatment. Ola-
Davies and Akinrinde, (2016) suggested that prolong 
arsenic exposure owing to accumulation in erythrocytes 
leads to a reduction in RBC and HGB as a result of 
inhibition of porphyrin or heme synthesis.  Elevated 
levels of WBC count indicate damage due to severe 
physical stress, infection of the body and toxic expo-
sure, and leukemia (Kumar et al., 2013).  Additionally, 
in this study, change in platelets counts indicated that 
arsenic inhibited the production of thrombopoietin. The 
finding indicates that chronic arsenic exposure causes 
severe damage to the liver that may have caused inhi-
bition of thrombopoietin production, resulting in a de-
crease in the platelets count (Wu et al., 2014; Peck-
Radosavljevic et al., 2000; 1997). Although, after the 
administration of fenugreek seeds extract, significant 
improvement in the hematological parameters - RBC, 
WBC, HGB, HCT levels were observed. Fenugreek 
seeds extract also improved liver functions and may 
Fig. 8. Albumin levels in different treated groups (control 
and treatment group). Values are expressed as mean ± 
SD, n=6; ***(p < 0.0001) compared with control group; ns
(non-significant) compared with arsenic treated group; ###
(p < 0.0001) compared with arsenic pretreated control 
group 
Fig. 7. Creatinine levels in different treated groups (control 
and treatment group). Values are expressed as mean  
± SD, n=6; ***(p < 0.0001) compared with control group; 
^^^(p < 0.0001), compared with arsenic treated group;  
###(p < 0.0001) compared with arsenic pretreated control 
group 
Fig. 9. Lipid peroxidation (MDA) levels in different treated 
groups (control and treatment group). Values are ex-
pressed as mean ± SD, n=6; ***(p < 0.0001) compared with 
control group; ^^(p < 0.001) compared with arsenic treated 
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also have increased the efficiency of iron storage and 
regulation of the proper hemoglobin synthesis. The liver 
also produced the thrombopoietin, which stimulated  
the platelets production (Mbarki et al., 2017; Ahmed  
et al., 2013). 
Arsenic interferes with the normal functioning of the 
vital organs such as the liver and kidney (Gomez-
Caminero et al., 2001). The liver is the major site of 
glutathione activity which detoxifies arsenic (Beesley, 
2018; Hedayati, 2016; Ratnaike, 2003). Methylated 
forms of trivalent arsenic causes liver toxicity through 
interaction with DNA and protein of the hepatocytes 
that in turn reduces methylation efficiency leading to 
the damage to hepatocytes and spill out hepatic bi-
omarker enzymes such as SGPT, SGOT, ALP and total 
bilirubin (Sharma et al., 2014; Klaassen and Watkins 
1984). In this study, there was a significant increase in 
SGPT, SGOT, ALP and total bilirubin after the arsenic 
treatment. Due to the loss of hepato-cellular function 
and loss of membrane integrity. The significant liver 
biochemical markers change can be correlated with 
liver histopathology. The hepatocellular architecture of 
the arsenic treated group showed hepatocytes degen-
eration with vacuolizations in sinusoids and haemor-
rhage in the portal vein. These results were consistent 
with the previous findings on arsenic and the increased 
oxidative stress in rats (Kumar et al., 2015b; Mershiba 
et al., 2013).  In contrast, after the administration of 
fenugreek seeds extract upon arsenic intoxicated rats, 
a significant decrease in the hepatic biomarker parame-
Fig. 10. Microphotograph of rat liver stained with hematoxylin and eosin (H&E X500). (A) Section of control rat liver 
showing normal arrangement of hepatocytes (H) & the central vein (CV) (H&E X500). (B) Section of arsenic treated rat 
liver showed degenerated hepatocytes and with haemorrhage in portal vein (PV) and hepatic arteries (HA) (H&E X500). 
(C) Section of arsenic pretreated control rat liver with still persistence of degeneration and vacuolization in the hepato-
cytes (H) along with the congestion in hepatic arteries and portal vein (PV) due to arsenic toxicity (H&E X500). (D) Sec-
tion of liver administered with fenugreek extract upon arsenic pretreated rat showing significant amelioration in the hepat-
ic histoarchitecture along with potal vein (PV)  and hepatic arteries (HA) (H&E X500). 
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ters - SGPT, SGOT, ALP and total bilirubin levels were 
observed, which denote its ameliorative property. They 
also stabilize the hepatocellular membrane and the 
histological alterations. Presently, quercetin and 
naringenin are the most active components of polyphe-
nol flavonoids present in fenugreek (Shang et al., 
1998), which inhibits the expression and signaling path-
ways by transforming growth factor- β-1 (TGF-β-1) and 
the synthesis of connective tissue proteins in activated 
hepatic stellate cells (HSCs) (Kang et al., 2001; Mao et 
al., 2004). The result of the present study suggests that 
the fenugreek seeds polyphenols and flavonoids play a 
significant role in mitigating the arsenic induced hepato-
toxicity.  
Various studies demonstrate that arsenic toxicity also 
causes renal damage. In case of chronic arsenic expo-
sure, after passing through the liver in the form of 
monomethylarsonic acid and dimethylarsinic acids, it 
reaches the kidney where they are filtered through 
glomerulus and are reabsorbed subsequently into the 
proximal tubules. And, if they remain in the tubular 
cells, they cause tubular damage (Rizwan et al., 2014; 
Wang et al., 2014; Peraza et al., 2006). Renal injury 
due to arsenic intoxication can be assayed by the se-
rum levels of urea, uric acid, creatinine and albumin. In 
the present study, significant alterations were observed 
in urea, uric acid, creatinine and albumin levels in the 
serum of arsenic treated rats. The histopathological 
study also showed very high degree of degeneration in 
nephrocytes, Bowman’s capsule, glomerulus, distal 
convoluted tubule and proximal convoluted tubule. 
These biochemical and histopathological alterations 
Fig. 11. Microphotograph of rat kidney stained with hematoxylin and eosin (H&E). (A) Section of control rat kidney  
showing normal architecture of Bowman’s capsule (BC) and glomerulus (GM) (H&E X800). (B) Arsenic treated rat kidney  
section showing degeneration in glomerulus (GM), significant vacuolization in Bowman’s capsule (BC) basement and in 
proximal and distal convoluted tubules (PCT and DCT) (H&E X500). (C) Arsenic pretreated control rat kidney section 
showed degeneration in the Bowman’s capsule (BC) and glomerulus (GM) along with haemorrhage in renal convoluted 
tubule denotes that there was no significant recovery in the nephrocytes (H&E X800). (D) The Fenugreek extract  
adminstraion upon arsenic pretreated rat kidney section showed significant restoration in the glomerulus (GM) and Bow-
man’s capsule (BC) along with the proximal and distal convoluted tubules (PCT and DCT) (H&E X800). 
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denote renal failure due to arsenic toxicity. The obser-
vations are consistent with other reports of arsenic in-
duced toxicity on rodent models (Sinha and Manna, 
2008; Majhi et al., 2011; Kumar et al., 2015b; Mershiba 
et al., 2013).  
After the administration with fenugreek seeds extract 
upon arsenic treated rats, there was a significant resto-
ration in the kidney at the biochemical and cellular lev-
els. The biochemical parameters reflected very signifi-
cant normalization in the urea, uric acid, creatinine and 
albumin levels, while at the cellular level, the normaliza-
tion in nephrocytes architecture and in their function 
was observed. This result illustrates the membrane 
stabilizing nature of fenugreek seeds extract as previ-
ously reported (Belaïd-Nouira et al., 2013). The antioxi-
dant activity of fenugreek, mentioned in various studies, 
is considered to be exerted by polyphenols, especially 
flavonoids. Xue et al. (2011) reported that fenugreek 
seeds were able to restore the renal function of diabetic 
rats, through its antioxidant activity.  A recent study by 
Uslu et al. (2019) also reported that fenugreek seeds 
normalizes serum marker and improves the histological 
changes against sodium nitrite intoxication in kidney 
and liver damage.  
Increasing MDA levels is the most important sign of 
oxidative (LPO) damage in cells. In the present study, a 
significant increase in the serum MDA levels was ob-
served in arsenic treated rats, which were reported in 
earlier studies (Kumar et al., 2015b, c).  Other studies 
revealed that arsenic toxicity caused a significant in-
crease in the rate of formation of reactive oxygen spe-
cies (ROS) such as hydrogen peroxide, superoxide 
anion radical and hydroxyl radical (Shi et al., 2004). 
ROS can lead to lipid peroxidation and degradation of 
the bilayer matrix of membrane lipid, resulting in deacti-
vation of membrane-bound receptors and increased 
tissue permeability (Adil et al., 2015). However, after 
the administration with fenugreek seeds extract, there 
was a significant reduction in the MDA levels compared 
to arsenic intoxicated rats. The present study results 
suggest that fenugreek polyphenols play a significant 
role in mitigating the LPO abnormalities against arsenic
-induced toxicity. Previous studies have also shown 
that fenugreek seeds are a rich source of polyphenols 
such as quercetin, apigenin, tricine, vitexin and 
kaempferol (Kenny et al., 2013; Benayad et al., 2014).  
Fenugreek extract has been found to reduce lipid pe-
roxidation and countered antioxidant status in blood 
and various organs in diabetic rats (Ravikumar and 
Anuradha, 1999; Genet et al., 2002). The present study 
indicated that fenugreek seeds have rich flavonoids 
that effectively reduce oxidative damage in arsenic  
intoxicated rats.  
Arsenic accumulation in the tissues and blood is a seri-
ous health concern to people living in arsenic exposed 
areas. High arsenic accumulation causes damage to 
the vital organs of our body with the rise of several dis-
eases, including cancer. Chronic arsenic exposure 
leads to arsenic accumulation in various organs such 
as liver, kidney, heart, lungs, muscles and spleen 
(Sayed et al., 2015; Dua et al., 2015; Ratnaike, 2003). 
In the present study, a significant high arsenic accumu-
lation was observed in the liver, kidney and blood of the 
arsenic treated group compared to the control group. 
The increased arsenic level denotes the high arsenic 
accumulation in the blood, liver and kidney tissue 
caused by chronic arsenic exposure. The results are in 
line with the studies from several other researchers, 
who have also observed high arsenic accumulation in 
the blood, liver and kidney tissues upon high arsenic 
exposure (Al-Forkan et al., 2016; De et al., 2016; Tan-
don et al., 2012; Nain and Smits, 2012). The liver, the 
primary organ responsible for arsenic metabolism, had 
higher arsenic accumulation than the kidney and blood. 
Hence, this study indicates that high level chronic arse-
nic exposure causes increased arsenic accumulation in 
the body's vital organs such as the liver and kidney, 
resulting in disrupted arsenic metabolism and excre-
tion. However, the fenugreek seeds extract seems to 
play a significant role in controlling the arsenic contami-
nation in the blood as well as in liver and kidney tis-
sues. Hence, fenugreek extract played a significant role 
in controlling arsenic poisoning in chronic arsenic ex-
posed experimental animals. Therefore, it can be rec-
ommended as a suitable antidote and therapeutic drug 
against arsenic toxicity in future. 
Conclusion 
The present study concluded that ethanolic extract of 
fenugreek (T. foenum-graecum L.) seeds possesses 
potential hepato-renal protection against arsenic  
induced toxicity in Charles Foster rats. The fenugreek 
seeds also possessed antitoxic effect against arsenic 
induced toxicity at the biochemical and cellular levels. 
Hence, the present study will develop a fenugreek-
based therapeutic drug in the future as a novel drug 
against arsenic toxicity for the exposed human  
population. 
ACKNOWLEDGEMENTS 
The authors are thankful to Anugrah Narayan College, 
Patna, Bihar, India, for infrastructural facilities; and Ma-
havir Cancer Sansthan and Research Center, Patna, 
Bihar, India, for the animal and laboratory facilities.  
Conflict of interest 




Kumar, V. et al. / J. Appl. & Nat. Sci. 13(3), 1083 - 1093 (2021) 
REFERENCES 
1. Adil, M., Kandhare, A. D., Visnagri, A. & Bodhankar, S. L. 
(2015). Naringin ameliorates sodium arsenite-induced 
renal and hepatic toxicity in rats: decisive role of KIM-1, 
Caspase-3, TGF-β, and TNF-α. Ren Fail, 37(8),1396-
1407, doi: 10.3109/0886022X.2015.1074462 
2. Ahmed Fadel Elseed A. M., Danil, T., Abu ElgaimAtta 
Elmanan, B. & Hassan, Ali O. (2013). Effects of fenugreek 
(Trigonella foenum-graecum) seeds saponin on digestibil-
ity, N-retention, Hematological parameters and blood Me-
tabolites in Rabbits. World's Vet. J., 3(3), 65-73. 
3. Al-Forkan, M., Islam, S., Akter, R., Shameen Alam, S., 
Khaleda, L., Rahman, Z. & Salma Chowdhury, D.U. 
(2016). A sub-chronic exposure study of arsenic on hema-
tological parameters, liver enzyme activities, histological 
studies and accumulation pattern of arsenic in organs of 
Wistar albino rats. J Cytol Histol, S.5(2). 
4. Barai, M., Ahsan, N., Paul, N., Hossain, K., Rashid, M.A., 
Kato, M., Ohgami, N. & Akhand, A.A. (2017). Amelioration 
of arsenic-induced toxic effects in mice by dietary supple-
mentation of Syzygium cumini leaf extract. Nagoya J Med 
Sci, 79(2),167-177, doi: 10.18999/nagjms.79.2.167 
5. Beesley, S. Chemicals, Metals and the Liver, Sarah Bees-
ley. (n.d.). 2018. https://selfhealclinic.co.nz/chemicals-
metals-and-the-liver/ 
6. Belaïd-Nouira, Y., Bakhta, H., Haouas, Z., Flehi-Slim, I. & 
Cheikh, H.B. (2013). Fenugreek seeds reduce aluminum 
toxicity associated with renal failure in rats. Nutr Res 
Pract, 7(6), 466-474, doi.org/10.4162/nrp.2013.7.6.466 
7. Benayad, Z., Gómez-Cordovés, C. and Es-Safi, N.E. 
(2014). Characterization of flavonoid glycosides from fen-
ugreek (Trigonella foenum-graecum) crude seeds by 
HPLC–DAD–ESI/MS analysis. Int. J. Mol. Sci., 15(11),206 
68-206685, doi:10.3390/ijms151120668 
8. Bhattacharya, A.K. (2019). Arsenic contamination in the 
groundwater of West Bengal, Jharkhand and Bihar with a 
special fFocus on the stabilization of arsenic-laden sludge 
from arsenic filters. EJGE, 24, 01-23. 
9. Chakraborti, D., Mukherjee, S.C., Pati, S., Sengupta, 
M.K., Rahman, M.M., Chowdhury, U.K., Lodh, D., Chan-
da, C.R., Chakraborti, A.K. & Basu, G.K. (2003). Arsenic 
groundwater contamination in Middle Ganga Plain, Bihar, 
India: a future danger?. Environ. Health Perspect., 111(9), 
1194-1201, doi: 10.1289/ehp.5966 
10. Chakraborti, D., Singh, S.K., Rahman, M.M., Dutta, R.N., 
Mukherjee, S.C., Pati, S. & Kar, P.B. (2018). Groundwater 
arsenic contamination in the Ganga River Basin: a future 
health danger. Int. J. Environ Res. Public Health, 15(2), 
180, doi: 10.3390/ijerph15020180. 
11. De, A., Nath, S., Bandyopadhyay, S.K., Mandal, T.K. & 
Das, A.K. (2016). Ameliorative effects of Bauhinia acu-
minata L stem bark powder against chronic arsenicosis in 
rats. Toxicol. Environ. Health Sci., 8(3), 258-262, 
doi.org/10.1007/s13530-016-0283-z 
12. Draper, H.H & Hadley, M. (1990) Malondialdehyde deter-
mination as index of lipid Peroxidation. In Methods in en-
zymology Jan 1 (Vol. 186, pp. 421-431). Academic press. 
13. Dua, T.K., Dewanjee, S., Gangopadhyay, M., Khanra, R., 
Zia-Ul-Haq, M. & De Feo, V. (2015). Ameliorative effect of 
water spinach, Ipomea aquatica (Convolvulaceae), 
against experimentally induced arsenic toxicity. J Transl 
Med,  1;13(1), 81, doi: 10.1186/s12967-015-0430-3. 
14. Ellenhorn, M.J., Schonwald, S., Ordog, G. & Wasser-
berger, I. (1997) Ellenhorn's. Medical Toxicology: Diagno-
sis and Treatment of Human Poisoning. 2nd ed. Balti-
more, MD: Williams and Wilkins. 1739-1764. 
15. Genet, S., Kale, R.K. & Baquer, N.Z. (2002). Alterations in 
antioxidant enzymes and oxidative damage in experi-
mental diabetic rat tissues: effect of vanadate and fenu-
greek (Trigonella foenum graecum). Mol Cell Biochem, 
236(1-2):7-12, doi: 10.1023/a:1016103131408. 
16. Gomez-Caminero, A., Howe, P.D., Hughes, M., Kenyon, 
E., Lewis, D.R., Moore, M., Aitio, A., Becking, G.C. & Ng, 
J. (2001) Arsenic and arsenic compounds, environmental 
health criteria. World Health Organization, Geneva. vol 
224. 
17. Hedayati, A. (2016). Liver as a target organ for eco-
toxicological studies. J Coast Zo Manage, 19:1-2, 
doi:10.4172/2473-3350.1000e118 
18. Hunter, F.T., Kip, A.F. & Irvine, J.W. (1942). Radioactive 
tracer studies on arsenic injected as potassium arsenite I. 
Excretion and localization in tissues. Journal of Pharma-
cology and Experimental Therapeutics, 76(2):207-220. 
19. International Plant Names Index (IPNI). (1753) The Her-
barium Catalogue, Royal Botanic Gardens, Kew, Trigonel-
la foenum-graecum | International Plant Names Index 
(ipni.org). 
20. Kang, L.P., Qi, L.H., Zhang, J.P., Shi, N., Zhang, M., Wu, 
T.M. & Chen, J. (2001). Effect of genistein and quercetin 
on proliferation, collagen synthesis, and type I procollagen 
mRNA levels of rat hepatic stellate cells. Acta Pharmaco-
logica Sinica, 22(9), 793-796. 
21. Kenny, O., Smyth, T.J., Hewage, C.M. and Brunton, N.P. 
(2013). Antioxidant properties and quantitative UPLC-MS 
analysis of phenolic compounds from extracts of fenu-
greek (Trigonella foenum-graecum) seeds and bitter mel-
on (Momordica charantia) fruit. Food Chem., 141(4), 4295
-4302, doi.org/10.1016/j.foodchem.2013.07.016 
22. Klaassen, C.D. & Watkins, J.B. (1984) Mechanisms of bile 
formation, hepatic uptake, and biliary excretion. Pharma-
col Rev, 36(1),1-67. 
23. Kumar, A., Ali, M., Kumar, R., Suman, S., Kumar, H., 
Nath, A., Singh, J.K. & Kumar, D. (2013) Withania somnif-
era protects the haematological alterations caused by 
Sodium arsenite in Charles foster rats. Int J Res Ayurveda 
Pharm, 4, 491-494, doi:10.7897/2277-4343.04405 
24. Kumar, A., Ali, M., Rahman, M.S., Iqubal, A., Anand, G., 
Niraj, P.K. & Kumar, R., (2015b). Antidote effects of plants 
of Himalayan sub-origin against arsenic induced toxicity. J 
Bio Chem Res, 2:99-109. 
25. Kumar, A., Ali, M., Rahman, S.M., Iqubal, A.M., Anand, 
G., Niraj, P.K., Shankar, P. & Kumar, R. (2015a). Ground 
water arsenic poisoning in “Tilak Rai Ka Hatta” village of 
Buxar district, Bihar, India causing severe health hazards 
and hormonal imbalance. J Environ Anal Toxicol, 5(4),1-7, 
doi: 10.4172/2161-0525.1000290 
26. Kumar, A., Kumar, R., Rahman, M.S., Iqubal, M.A., 
Anand, G., Niraj, P.K. & Ali, M. (2015c) Phytoremedial 
effect of Withania somnifera against arsenic-induced tes-
ticular toxicity in Charles Foster rats. Avicenna J Phy-
tomed, 5(4), 355. 
27. Liu, S.X., Athar, M., Lippai, I., Waldren, C. & Hei, T.K. 
(2001). Induction of oxyradicals by arsenic: implication for 
1092 
 
Kumar, V. et al. / J. Appl. & Nat. Sci. 13(3), 1083 - 1093 (2021) 
mechanism of genotoxicity. Proc. Natl. Acad. Sci., 98(4), 
1643-1648, doi: 10.1073/pnas.031482998 
28. Majhi, C.R., Khan, S., Leo, M.D.M., Manimaran, A., 
Sankar, P. & Sarkar, S.N. (2011). Effects of acetamino-
phen on reactive oxygen species and nitric oxide redox 
signaling in kidney of arsenic-exposed rats. Food Chem 
Toxicol, 49(4):974-982, doi: 10.1016/j.fct.2011.01.003. 
29. Mao, Y.Q., Liu, X.J., Jiang, Y. & Wu, H.B. (2004). Effect of 
quercetin on the signal pathway of TGFbeta1 in activated 
hepatic stellate cells. Journal of Sichuan University, Medi 
Sci Edi, 35(6), 802-805. 
30. Mbarki, S., Alimi, H., Bouzenna, H., Elfeki, A. & Hfaiedh, 
N. (2017). Phytochemical study and protective effect of 
Trigonella foenum graecum (Fenugreek seeds) against 
carbon tetrachloride-induced toxicity in liver and kidney of 
male rat. Biomed Pharmacother, 88,19-26, doi: 10.1016/
j.biopha.2016.12.078 
31.
 Mershiba, S.D., Dassprakash, M.V. & Saraswathy, S.D. 
(2013). Protective effect of naringenin on hepatic and 
renal dysfunction and oxidative stress in arsenic intoxicat-
ed rats. Mol Biol Rep, 40(5), 3681-3691, doi: 10.1007/
s11033-012-2444-8 
32. Nain, S. & Smits, J.E. (2012) Pathological, immunological 
and biochemical markers of subchronic arsenic toxicity in 
rats. Environ. Toxicol., 27(4), 244-254, doi: 10.1002/tox.20 
635 
33. NIOSH (National Institute for Occupational Safety and 
Health). (1994) Elements in blood or tissue. Method: 
8005. In: NIOSH manual of analytical methods. 4 Edn. 
O.H. Cincinnati: Department of Health and Human Ser-
vice, National Institute of Occupational Safety and Health. 
DHHS publication, 94–113. 
34. Ola-Davies, O.E. & Akinrinde, A.S. (2016). Acute sodium 
Arsenite-induced hematological and biochemical changes 
in wistar rats: Protective effects of ethanol extract of Ager-
atum conyzoides. Pharmacognosy Res., 8(1), 26, doi: 
10.4103/0974-8490.178645 
35. Peck-Radosavljevic, M., Wichlas, M., Zacherl, J., Stiegler, 
G., Stohlawetz, P., Fuchsjäger, M., Kreil, A., Metz-
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